Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules.

被引:96
|
作者
Khalaf, Majid [1 ,4 ]
Abdel-Nabi, Hani [1 ]
Baker, John [1 ]
Shao, Yiping [1 ]
Lamonica, Dominick [2 ]
Gona, Jayakumari [3 ]
机构
[1] SUNY Buffalo, Dept Nucl Med, Buffalo, NY 14260 USA
[2] Roswell Pk Canc Inst, Dept Nucl Med, Buffalo, NY 14263 USA
[3] Vet Affairs Western New York Healthcare Syst, Dept Nucl Med, Buffalo, NY USA
[4] Childrens Hosp Michigan, PET Ctr, Detroit, MI 48201 USA
关键词
D O I
10.1186/1756-8722-1-13
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
: The most common semiquantitative method of evaluation of pulmonary lesions using F-18-FDG PET is FDG standardized uptake value (SUV). An SUV cutoff of 2.5 or greater has been used to differentiate between benign and malignant nodules. The goal of our study was to investigate the correlation between the size of pulmonary nodules and the SUV for benign as well as for malignant nodules. Methods: Retrospectively, 173 patients were selected from 420 referrals for evaluation of pulmonary lesions. All patients selected had a positive CT and PET scans and histopathology biopsy. A linear regression equation was fitted to a scatter plot of size and SUVmax for malignant and benign nodules together. A dot diagram was created to calculate the sensitivity, specificity, and accuracy using an SUVmax cutoff of 2.5. Results: The linear regression equations and (R-2)s as well as the trendlines for malignant and benign nodules demonstrated that the slope of the regression line is greater for malignant than for benign nodules. Twenty-eight nodules of group one (<= 1.0 cm) are plotted in a dot diagram using an SUVmax cutoff of 2.5. The sensitivity, specificity, and accuracy were calculated to be 85%, 36% and 54% respectively. Similarly, sensitivity, specificity, and accuracy were calculated for an SUVmax cutoff of 2.5 and found to be 91%, 47%, and 79% respectively for group 2 (1.1-2.0 cm); 94%, 23%, and 76%, respectively for group 3 (2.1-3.0 cm); and 100%, 17%, and 82%,, respectively for group 4 (> 3.0 cm). The previous results of the dot diagram indicating that the sensitivity and the accuracy of the test using an SUVmax cutoff of 2.5 are increased with an increase in the diameter of pulmonary nodules. Conclusion: The slope of the regression line is greater for malignant than for benign nodules. Although, the SUVmax cutoff of 2.5 is a useful tool in the evaluation of large pulmonary nodules (>1.0 cm), it has no or minimal value in the evaluation of small pulmonary nodules (<= 1.0 cm).
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules.
    Majid Khalaf
    Hani Abdel-Nabi
    John Baker
    Yiping Shao
    Dominick Lamonica
    Jayakumari Gona
    Journal of Hematology & Oncology, 1
  • [2] Change in SUV of solitary pulmonary nodules (SPN) in delayed 18F-FDG PET imaging:: Benign vs malignant nodules.
    Sinha, P
    Conrad, GR
    Couch, W
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 154P - 155P
  • [3] Dual time point 18FDG-PET imaging for the differentiation between benign and malignant pulmonary nodules.
    Matthies, A
    Smith, RJ
    Cuchiara, AJ
    Alavi, AA
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 293P - 293P
  • [4] F-18-FDG PET in the evaluation of small solitary pulmonary nodules.
    Weber, W
    Romer, W
    Ziegler, S
    Schad, D
    Herz, M
    Kruschke, C
    Prauer, H
    Schwaiger, M
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 435 - 435
  • [5] Association of 18F-FDG-PET SUV and Tumor Size in Cervical Cancer
    Paul, A. G.
    Heilbrun, L. K.
    Smith, D. W.
    Miller, S. R., II
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E632 - E632
  • [6] The role of 18F-FDG PET or 18F-FDG-PET/CT in the evaluation of solitary pulmonary nodules
    Li, Wenbo
    Pang, Hua
    Liu, Qiong
    Zhou, Jing
    EUROPEAN JOURNAL OF RADIOLOGY, 2015, 84 (10) : 2032 - 2037
  • [7] The clinical efficacy of 18F-FDG-PET/CT in benign and malignant musculoskeletal tumors
    Duk-Seop Shin
    Oog-Jin Shon
    Dong-Sung Han
    Joon-Hyuk Choi
    Kyung-Ah Chun
    Ihn-Ho Cho
    Annals of Nuclear Medicine, 2008, 22
  • [8] The clinical efficacy of 18F-FDG-PET/CT in benign and malignant musculoskeletal tumors
    Shin, Duk-Seop
    Shon, Oog-Jin
    Han, Dong-Sung
    Choi, Joon-Hyuk
    Chun, Kyung-Ah
    Cho, Ihn-Ho
    ANNALS OF NUCLEAR MEDICINE, 2008, 22 (07) : 603 - 609
  • [9] 18F-FDG-PET/CT in malignant mesothelioma
    Fuccio, Chiara
    Spinapolice, Elena Giulia
    Ferretti, Alice
    Castellucci, Paolo
    Marzola, Maria Cristina
    Trifiro, Giuseppe
    Rubello, Domenico
    BIOMEDICINE & PHARMACOTHERAPY, 2013, 67 (06) : 539 - 542
  • [10] 18F-FDG-PET SUV AS A PROGNOSTIC MARKER OF INCREASING SIZE IN THYROID CANCER TUMORS
    Singh, Ishita
    Bikas, Athanasios
    Garcia, Carlos A.
    Desale, Sameer
    Wartofsky, Leonard
    Burman, Kenneth D.
    ENDOCRINE PRACTICE, 2017, 23 (02) : 182 - 189